m+Medelevator.RU
← Поиск публикаций
Immunity · 2026

Antibody responses against bacterial glycans affinity mature and diversify in germinal centers.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Fryer Holly A, Pitt Catherine, Frost Hannah R, Kandhari Nitika, Byars Sean, Lim Pailene S, Fettes Rhiannon L, Lovett Reece M, Nguyen Trang T, Chheng Kaneka, Caltabiano Natalie, Whitcombe Alana L, Hamelink Julianne, Andrew Dean, Lloyd Gareth, Wilson-Boyd Brian, Slee Nicola, Ballantine Jodie, Vasani Sarju, Girling Kathryn, Gubbels Liam, Levi Eric, Davies Karen, Tangye Stuart G, Noonan Jonathan, Moreland Nicole J, Quast Isaak, Robinson Marcus J, Scally Stephen W, Neeland Melanie R, Shanthikumar Shivanthan, Osowicki Joshua, Tarlinton David M, Steer Andrew C, Boyle Michelle J, Hill Danika L

Аннотация

Anti-carbohydrate antibodies (Abs) play crucial roles in pathogen control, but their generation remains poorly understood. Here, we studied how B cell immunity against the Streptococcus pyogenes surface polysaccharide is influenced by age and antigen (Ag) exposure across human blood, spleen, and tonsils. The glycan-targeted response shifted from immunoglobulin M (IgM) biased in children toward IgG and IgA biased in adults. Both natural colonization and controlled human infection with S. pyogenes increased class-switched B cells, with evidence of within-clone switching. Glycan-specific B cells readily engaged in germinal center (GC) responses and underwent robust somatic hypermutation (SHM) but had reduced expression of T cell help-associated molecules, correlating with lower antibody-secreting cell (ASC) output. Thus, mucosal pathogen encounters elicit glycan responses that class switch, evolve, and diversify through the GC, with implications for the design and schedule of glycan-containing vaccines.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты